EMILY BOUCHER: Open Payments
NPI 1447993985 · ABINGDON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,727 in 93 payments from 22 companies in 2025. Trend: 2023 $3,937 · 2024 $1,948 · 2025 $1,727
Food & beverage: $1,727
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 27 | $517 |
| Amgen Inc. | 15 | $168 |
| Insulet Corporation | 5 | $127 |
| BETA BIONICS, INC. | 2 | $119 |
| Lilly USA, LLC | 12 | $111 |
| Dexcom, Inc. | 5 | $97 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $69 |
| Novartis Pharmaceuticals Corporation | 3 | $59 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
Products named: Rybelsus, Ozempic, Omnipod, iLet Bionic Pancreas, MOUNJARO, Dexcom G6 Transmitter, REPATHA, JARDIANCE.
Industry payments across VA — which companies pay providers there.
